Pricing Log in Create free account

Disc Medicine, Inc. (IRON) vs Pharvaris N.V. (PHVS)

Disc Medicine, Inc. and Pharvaris N.V. are both Biotechnology companies. Disc Medicine, Inc. and Pharvaris N.V. are of similar size ($2.2B and $2.1B). Across the 9 metrics below, Disc Medicine, Inc. leads on 5 and Pharvaris N.V. on 4.

Valuation

Metric IRON PHVS Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 3.41 5.41 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (11.58%) (10.96%) (33.15%)
Free cash flow yield (9.03%) (9.41%) (25.50%)

Profitability

Metric IRON PHVS Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (39.08%) (71.50%) (56.36%)
Return on assets (35.12%) (64.43%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IRON PHVS Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (51.77%) (25.37%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IRON PHVS Biotechnology median
Debt to equity 0.09 0.00 0.00
Current ratio 24.14 11.94 4.72
Net debt to EBITDA 3.12 1.72 0.96

Dividend

Metric IRON PHVS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IRON PHVS Biotechnology median
Market cap 2.17b 2.07b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack